You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

~ Buy the CALCIUM ACETATE Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

CALCIUM ACETATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Calcium Acetate, and what generic alternatives are available?

Calcium Acetate is a drug marketed by Amneal Pharms, Chartwell Rx, Heritage Pharms Inc, Hikma, Invagen Pharms, Lotus Pharm Co Ltd, Lupin Ltd, Nostrum Labs Inc, Square Pharms, Suven Pharms, Chartwell Molecular, and Padagis Us. and is included in fourteen NDAs.

The generic ingredient in CALCIUM ACETATE is calcium acetate. There are two hundred and eighty-two drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the calcium acetate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Calcium Acetate

A generic version of CALCIUM ACETATE was approved as calcium acetate by HIKMA on February 26th, 2008.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CALCIUM ACETATE?
  • What are the global sales for CALCIUM ACETATE?
  • What is Average Wholesale Price for CALCIUM ACETATE?
Drug patent expirations by year for CALCIUM ACETATE
Drug Prices for CALCIUM ACETATE

See drug prices for CALCIUM ACETATE

Drug Sales Revenue Trends for CALCIUM ACETATE

See drug sales revenues for CALCIUM ACETATE

Recent Clinical Trials for CALCIUM ACETATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Peking University People's HospitalPhase 2
Mark FoxPhase 4
University of Colorado, DenverPhase 2

See all CALCIUM ACETATE clinical trials

Pharmacology for CALCIUM ACETATE
Paragraph IV (Patent) Challenges for CALCIUM ACETATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
PHOSLYRA Oral Solution calcium acetate 667 mg/5 mL 022581 2 2013-12-05
PHOSLO GELCAPS Capsules calcium acetate EQ 169 mg calcium 021160 1 2005-05-31

US Patents and Regulatory Information for CALCIUM ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms CALCIUM ACETATE calcium acetate CAPSULE;ORAL 201658-001 Oct 6, 2014 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Lupin Ltd CALCIUM ACETATE calcium acetate CAPSULE;ORAL 202127-001 Jul 9, 2015 AB RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hikma CALCIUM ACETATE calcium acetate CAPSULE;ORAL 077728-001 Feb 26, 2008 AB RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

CALCIUM ACETATE Market Analysis and Financial Projection Experimental

Calcium Acetate Market Dynamics and Financial Trajectory

Introduction to Calcium Acetate

Calcium acetate is a chemical compound widely used in various industries, including food, pharmaceuticals, and textiles. Its versatility and essential applications make it a significant player in the global market.

Market Size and Growth Projections

The global calcium acetate market is anticipated to experience moderate yet steady growth over the coming years. By 2032, the market is projected to reach a value of approximately USD 0.09 billion, growing at a Compound Annual Growth Rate (CAGR) of 3.1%[5].

Regional Market Dynamics

Asia-Pacific

The Asia-Pacific region is expected to see high demand for calcium acetate, driven by increasing population, changing lifestyles, and growing end-user sectors such as food and beverages, and pharmaceuticals. Countries like India, Japan, Thailand, and Indonesia are key contributors to this growth due to rising income levels and improving lifestyles[1][4].

Europe

Europe is forecasted to lead the calcium acetate market, despite facing headwinds from a saturated market. The region's strong demand is supported by significant investments in Research and Development (R&D) activities, particularly in the pharmaceutical and food industries[4].

North America

In North America, the calcium acetate market has shown resilience despite logistical complexities and trade tensions. The demand remains strong, especially from the food and pharmaceutical sectors. However, the market faces challenges such as high inventory levels and reduced downstream inquiries, which can impact price trends[2].

Latin America and MEA

Latin America and the Middle East & Africa (MEA) regions are also expected to see increased demand for calcium acetate, driven by expanding end-user sectors and growing industrial applications[1].

Price Trends and Market Sentiment

Current Price Trends

The price of calcium acetate has been on an upward trajectory, influenced by rising procurement rates from downstream industries such as food and pharmaceuticals. In the first quarter of 2024, European and North American markets saw positive price trends due to strong demand and stabilized energy production costs[2].

Factors Influencing Prices

Several factors contribute to the price stability and growth of calcium acetate:

  • Feedstock Costs: Rising feedstock costs, particularly for acetic acid and calcium carbonate, have driven up the prices of calcium acetate[2].
  • Supply Chain Disruptions: Logistical challenges, including geopolitical tensions and Houthi attacks on Asian shipments, have affected export volumes and profit margins[2].
  • Demand from End-User Industries: Strong demand from the food, pharmaceutical, and construction industries has supported the upward price trend[2].

Key Applications and End-User Industries

Food and Beverages

Calcium acetate is widely used as a preservative and food additive, particularly in dairy products like milk powder, cream, and condensed milk. Its role as a clean label additive is gaining traction, driving demand in the food and beverage sector[4].

Pharmaceuticals

In the pharmaceutical industry, calcium acetate is crucial for blood dialysis, where it helps regulate blood phosphate levels. This application is a significant driver of market growth[4].

Textiles and Other Industries

Calcium acetate is also used in the production of soaps, detergents, and as a blowing material in PVC foam manufacturing. These diverse applications contribute to the market's overall growth[4].

Competitive Landscape

The calcium acetate market is relatively consolidated, with key players such as Alemark, Merck Millipore, GFS Chemicals, Richman Chemical, and Allan Chemical Corp. These companies leverage economies of scale and strategic alliances with end-user industries to maintain a competitive edge[4].

Regulatory and Market Challenges

Regulatory Requirements

Stringent regulatory requirements, especially in North America, pose challenges to market growth. Overcapacities in the region also restrict market expansion[4].

Market Saturation

Europe faces challenges from a saturated market, which can limit growth opportunities. However, investments in R&D and diversification of applications help mitigate these challenges[4].

Future Outlook and Opportunities

Emerging Markets

Investing in emerging markets such as India and China is crucial for market leadership. These regions offer lucrative opportunities due to low labor costs and growing demand[4].

Strategic Alliances

Collaborations with leaders in end-use industries, such as PVC foam manufacturers, can provide significant growth opportunities for calcium acetate producers[4].

Analyst Insights

"The price trend of Calcium Acetate is expected to move northwards in the forthcoming quarters as the cost support provided by the feedstock commodities and end-user industries is likely to drive the market in a positive direction."[2]

Key Takeaways

  • The global calcium acetate market is projected to grow at a CAGR of 3.1% to reach USD 0.09 billion by 2032.
  • Asia-Pacific and Europe are key regions driving market growth due to increasing demand from food, pharmaceutical, and other industries.
  • Strong demand from downstream industries and rising feedstock costs are driving the upward price trend.
  • Strategic alliances and investments in emerging markets are crucial for market leadership.
  • Regulatory challenges and market saturation in certain regions need to be addressed to sustain growth.

FAQs

1. What is the projected market size of the global calcium acetate market by 2032? The global calcium acetate market is expected to reach USD 0.09 billion by 2032[5].

2. What is the CAGR of the calcium acetate market from 2023 to 2032? The calcium acetate market is expected to exhibit a CAGR of 3.1% from 2023 to 2032[5].

3. Which regions are expected to drive the growth of the calcium acetate market? Asia-Pacific and Europe are expected to be the key drivers of the calcium acetate market growth, with significant contributions from countries like India, Japan, and Thailand[1][4].

4. What are the primary applications of calcium acetate? Calcium acetate is primarily used as a preservative and food additive in the food industry, in blood dialysis in the pharmaceutical sector, and in various industrial applications such as PVC foam production[4].

5. Who are the key players in the calcium acetate market? Key players include Alemark, Merck Millipore, GFS Chemicals, Richman Chemical, and Allan Chemical Corp., among others[4].

Sources

  1. Fact.MR - Calcium Acetate Market Size, Share and Statistics - 2034
  2. Procurement Resource - Calcium Acetate Price Trend, Index, News, Chart, Database
  3. Grand View Research - Calcium Acetate Market Size, Share | Global Industry Report, 2019
  4. Future Market Insights - Calcium Acetate Market Sales, Analysis & Opportunities | FMI
  5. Business Research Insights - Calcium Acetate Market Size, Share & Growth Report to 2032

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.